Home › Research › Topics › metabolic-syndrome
metabolic-syndrome
304 studies tagged metabolic-syndrome, dated 1984-04-01 to 2026-10-26. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Interventions for Cognitive Impairment in Type 2 Diabetes Mellitus: An Umbrella Review of Pharmacological and Lifestyle Strategies, Mechanisms, and Clinical Implications 2026-10-26
- Visit-to-Visit Blood Pressure Variability, Glycemic Status and the Risk of Dementia, Stroke, and All-Cause Mortality: A UK Biobank Cohort Study 2026-10-13
- Plasma metabolomic profiling of frailty in older adults at risk of dementia 2026-10-08
Studies
304 studies carry this tag.
Date range
1984 to 2026
Top journals
- Journal of Alzheimer's disease : JAD 21
- medRxiv 16
- Alzheimer's & dementia : the journal of the Alzheimer's Association 14
- Neurology 10
- Nutrients 10
164 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The incidence of dementia is expected to double in the next 20 years and will contribute to heavy social and economic burden.
-
Our findings demonstrate that 10-year CP exposure was associated with a 1.707-fold increase in the risk of developing AD.
-
Epidemiological evidence reveals that patients with type 2 diabetes mellitus (T2DM) have an increased risk of neurodegenerative diseases (NDs), including dementia and Parkinson's disease (PD).
-
Dementia and osteoporosis are multifaceted disease processes with similar epidemiology and a marked increase in prevalence in elderly populations.
-
These results indicate that the use of statins may benefit all AD patients with potentially greater therapeutic efficacy in those homozygous for ApoE4.
-
Some observational studies raised concern that statins may cause memory impairment, leading to a US Food and Drug Administration warning.
-
However, several drugs prescribed for other conditions have been associated with reducing its risk.
-
Metabolic syndrome (MetS) is a common and complex disorder combining hypertension, obesity, dyslipidemia, and insulin resistance.
-
Androgen deprivation therapy in the treatment of prostate cancer may be associated with an increased risk of dementia.
-
Future research is warranted to examine the mechanistic basis of treatment differences, and to further assess the efficacy and safety of intranasal insulin.
-
IR is related to subsequent poorer cognitive performance and greater cognitive decline among patients with cardiovascular disease with and without diabetes.
-
Among metabolic syndrome components, the effects of higher plasma glucose levels on cognitive decline (CD) have been considered in few studies.
-
White Matter Disease is increasingly being recognized as an important cause of cognitive decline and dementia.
-
Alzheimer's disease (AD) is an age-related neurodegenerative disorder for which there are no effective strategies to prevent or slow its progression.
-
Due to complex relationships of body-mass index and blood pressure with dementia individual components cancelled each other out and rendered the sum-scores meaningless for the prediction of dementia.
-
Dementia, closely linked to environmental predisposing factors such as diet, is a public health problem of increasing magnitude: currently there are more than 35 million patients with Alzheimer´s disease, and is expected to exceed 135 million by 2050.
-
This study supports the conclusions that diabetes increases the risk of cerebrovascular but not Alzheimer's disease pathology, and at least some of diabetes' relationship to cognitive impairment may be modified by neuropathology.
-
We believe that ours is the largest blood biomarker study of preclinical AD to date.
-
Diabetes and hyperinsulinemia may be risk factors for Alzheimer's disease (AD).
-
Alzheimer's disease (AD) is currently the most common incurable forms of dementia.
-
Our results support an association between the use of ADT in the treatment of prostate cancer and an increased risk of Alzheimer's disease in a general population cohort.
-
38/100
Unlike Alzheimer's, vascular dementia can, in part, be prevented.
-
Effective interventions in diet, medications, biochemical exposures, psychological condition, pre-existing disease and lifestyle may decrease new incidence of AD.
-
The large majority of neuroimaging studies in Alzheimer's disease (AD) patients have supported the idea that lifestyle factors may protect against the clinical manifestations of AD rather than influence AD neuropathological processes (the cognitive reserve hypothesis).
-
In multivariate voxel-by-voxel analyses, adherence to the MeDi was significantly associated with preserved white matter microstructure in extensive areas, a gain in structural connectivity that was related to strong cognitive benefits.
-
Diabetic patients have an elevated risk of dementia, and comorbidity increases this risk.
-
Inherited lifetime exposure to higher SBP is associated with lower AD risk.
-
Patients with gout have a lower risk of developing dementia.
-
Plasma DES/CHO was significantly reduced in Japanese AD patients and significantly correlated with Mini-Mental State Examination (MMSE) score.
-
76/100
Statin therapy was not associated with cognitive impairment in RCTs.
-
Improvements in leptin and ghrelin levels following bariatric surgery appear to contribute to postoperative cognitive benefits.
-
The variations of fatty acid levels and the accumulation of C26:0 in the plasma and RBCs highlight an alteration of fatty acid metabolism in demented patients and point toward possible peroxisomal dysfunction.
-
RECENT FINDINGS: Based on available epidemiological studies, two meta-analyses published in 2013 have underlined a protective effect of a greater MeDi adherence on cognitive health, including a reduced risk of Alzheimer's disease and cognitive impairment.
-
38/100
Benefits of dietary moderation when on a Mediterranean diet type (MD) have been known for well over half a century.
-
The incidence of MCR is high in older adults.
-
Cardiovascular risk factors (CRF) were widely described as related to dementia.
-
A reduction in the incidence of smoking will likely reduce the future prevalence of AD.
-
38/100
Considerable attention has focused on the prevention of dementia in terms of non-genetic risk factors, including midlife obesity, especially visceral obesity associated with hyperglycemia, hypertension, and hypercholesterolemia.
-
Newly diagnosed DM was associated with increased risk of AD.
-
There is growing evidence for the importance of cardiovascular risk factors in dementia development, including Alzheimer's disease.
-
Larger and better-designed studies are needed to draw unequivocal conclusions about the effect of statins on cognition.
-
These findings suggest that cognitive benefits of bariatric surgery may extend to 24-months postoperatively.
-
In patients without baseline cognitive dysfunction, short-term data are most compatible with no adverse effect of statins on cognition, and long-term data may support a beneficial role for statins in the prevention of dementia.
-
52/100
Metformin use was associated with impaired cognitive performance.
-
40/100
The frailty syndrome has recently attracted attention of the scientific community and public health organizations as precursor and contributor of age-related conditions (particularly disability) in older persons.
-
Diuretic, ARB, and ACE-I use was, in addition to and/or independently of mean systolic blood pressure, associated with reduced risk of AD dementia in participants with normal cognition, while only diuretic use was associated with reduced risk in participants with MCI.
-
Alzheimer's disease (AD) affects approximately 35 million people worldwide.
-
Participants in the hypertension group with at least 1 ε4 allele showed significantly greater amyloid burden than those with only 1 risk factor or no risk factors.
-
The disturbances of the cholesterol synthesis and metabolism described in Alzheimer's disease (AD) may be both a consequence of the neurodegenerative process and a contributor to the pathogenesis.
-
The biomarker profile for AD among Mexican American cases is significantly different from that previously identified among non-Hispanic cases from many large-scale studies.
From across this tag
6 of the 304 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 6. The same 6 appear here every time.
- Cigarette Smoking is a Risk Factor for Alzheimer's Disease: An Analysis Controlling for Tobacco Industry Affiliation
- Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
- Cholesterol profiles and incident cognitive decline among older adults: the Shanghai Aging Study
- Verbal Fluency in Metabolic Syndrome
- A Study on the Association Between the Course of Heart Failure and Cognitive Function in Older Adults: Based on Data from the 2011–2014 National Health and Nutrition Examination Survey
- Associations between cerebrovascular risk factors and parkinson disease